BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11469928)

  • 21. Predictors of surgical margin status in breast-conserving surgery within a breast screening program.
    Kurniawan ED; Wong MH; Windle I; Rose A; Mou A; Buchanan M; Collins JP; Miller JA; Gruen RL; Mann GB
    Ann Surg Oncol; 2008 Sep; 15(9):2542-9. PubMed ID: 18618180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
    Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
    Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
    Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
    Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands.
    van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
    Breast; 2014 Feb; 23(1):63-8. PubMed ID: 24291376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A single-center retrospective study on axillary evaluation in 1 557 breast ductal carcinoma in situ patients between 2006 and 2016].
    Si J; Quan CL; Mo M; Guo R; Su YH; Yang BL; Chen JJ; Shao ZM; Wu J
    Zhonghua Wai Ke Za Zhi; 2019 Sep; 57(9):681-685. PubMed ID: 31474060
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluating the role of sentinel lymph node biopsy in patients with DCIS treated with breast conserving surgery.
    James TA; Palis B; McCabe R; Pardo JA; Alapati A; Ukandu O; Serres SK; Zhang J; Mele A; Facktor M; Shulman LN
    Am J Surg; 2020 Sep; 220(3):654-659. PubMed ID: 31964523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation.
    Solin LJ; Fowble BL; Yeh IT; Kowalyshyn MJ; Schultz DJ; Weiss MC; Goodman RL
    Int J Radiat Oncol Biol Phys; 1992; 23(5):961-8. PubMed ID: 1322388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
    J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reducing harms from treatment. Sixteen years of surgery of the axilla for screen-detected breast cancers in Italy.
    Lazzaretti MG; Ponti A; Mano MP; Barca A; Casella D; Frigerio A; Giordano L; Mantellini P; Paduos A; Pitarella S; Ravaioli A; Taffurelli M; Tomatis M; Segnan N
    Breast; 2018 Dec; 42():15-22. PubMed ID: 30138762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.
    Rakovitch E; Nofech-Mozes S; Narod SA; Hanna W; Thiruchelvam D; Saskin R; Taylor C; Tuck A; Sengupta S; Elavathil L; Jani PA; Done SJ; Miller N; Youngson B; Kong I; Paszat L
    Breast Cancer Res Treat; 2013 Apr; 138(2):581-90. PubMed ID: 23456231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
    Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE
    Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
    Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
    Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgeon Variability and Factors Predicting for Reoperation Following Breast-Conserving Surgery.
    Valero MG; Mallory MA; Losk K; Tukenmez M; Hwang J; Camuso K; Bunnell C; King T; Golshan M
    Ann Surg Oncol; 2018 Sep; 25(9):2573-2578. PubMed ID: 29786129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
    Rakovitch E; Nofech-Mozes S; Hanna W; Baehner FL; Saskin R; Butler SM; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Robertson SJ; Slodkowska E; Fong C; Anderson JM; Jamshidian F; Miller DP; Cherbavaz DB; Shak S; Paszat L
    Breast Cancer Res Treat; 2015 Jul; 152(2):389-98. PubMed ID: 26119102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nipple-sparing mastectomy as treatment for patients with ductal carcinoma in situ: A 10-year follow-up study.
    Lago V; Maisto V; Gimenez-Climent J; Vila J; Vazquez C; Estevan R
    Breast J; 2018 May; 24(3):298-303. PubMed ID: 29139613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgeon Volume, Patient Age, and Tumor-Related Factors Influence the Need for Re-Excision After Breast-Conserving Surgery.
    Hughes L; Hamm J; McGahan C; Baliski C
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):656-664. PubMed ID: 27718033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Effectiveness of Surgical Options for Patients with Ductal Carcinoma In Situ: An Instrumental Variable Approach.
    Duan L; Kawatkar AA
    Perm J; 2018; 22():17-132. PubMed ID: 30028673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in the treatment of ductal carcinoma in situ of the breast.
    Baxter NN; Virnig BA; Durham SB; Tuttle TM
    J Natl Cancer Inst; 2004 Mar; 96(6):443-8. PubMed ID: 15026469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conservative excision of wire-bracketed breast carcinomas: a community hospital's experience.
    Florentine BD; Kirsch D; Carroll-Johnson RM; Senofsky G
    Breast J; 2004; 10(5):398-404. PubMed ID: 15327492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.